Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function in real-world patients
Conclusion:
From the present findings based on the real-world data, ARBs can be recommended for kidney protection even in a primary care setting. Meanwhile, dCCB treatment initially increases eGFR with no adverse effects on proteinuria.
Source: Journal of Hypertension - Category: Cardiology Tags: ORIGINAL ARTICLES Source Type: research
More News: Calcium | Cardiology | Hypertension | Primary Care | Proteinuria | Study | Urology & Nephrology